On ECHEMI
Home > Drugs > Cerebral hemorrhage
Cerebral hemorrhage
Cerebral hemorrhage, also known as cerebral hemorrhage, has various causes, most of which are caused by rupture of blood vessels due to hypertension and arteriosclerosis, so some people also call it hypertensive cerebral hemorrhage. According to whether it is caused by traumatic factors, it can be divided into traumatic intraventricular hemorrhage and spontaneous intraventricular hemorrhage. The close relationship between cerebral hemorrhage and hypertension is that about 1/3 of patients with hypertension have a chance of cerebral hemorrhage, and about 95% of patients with cerebral hemorrhage have hypertension. Cerebral hemorrhage is a common acute cerebrovascular disease in middle-aged and elderly people, with a high mortality rate and disability rate. It is the clinical type with the highest mortality rate among cerebrovascular diseases in my country. Cerebral hemorrhage accounts for 40% to 50% of all cerebrovascular diseases. 80% of cerebral hemorrhage occurs in the cerebral hemispheres, and 20% occurs in the lobes, brainstem, cerebellum and ventricles.
Related Drugs
Tranexamic Acid Injection
Indication: 1. This product is mainly used for various bleeding caused by acute or chronic, localized or systemic primary hyperfibrinolysis. For secondary hyperfibrinolytic state caused by disseminated intravascular coagulation, this product is generally not used before heparinization. 2. It is used for trauma or surgical bleeding in organs rich in plasminogen activators such as the prostate, urethra, lungs, brain, uterus, adrenal glands, and thyroid glands. 3. It is used as an antagonist of tissue plasminogen activator (t-PA), streptokinase, and urokinase. 4. It is used for fibrinolytic bleeding caused by artificial abortion, early placental abruption, stillbirth, and amniotic fluid embolism, as well as menorrhagia caused by pathological increased local fibrinolysis in the uterine cavity. 5. It is used for mild bleeding caused by central nervous system diseases, such as subarachnoid hemorrhage and intracranial aneurysm bleeding. The use of this product is superior to other anti-fibrotic drugs in stopping bleeding.
Manufacturer:

Chongqing Lummy Pharmaceutical Co., Ltd.

Gynecological Ten Tablets
Manufacturer:

Jiuzhitang Co., Ltd.

Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:

Shanghai Sine Tianping Pharmaceutical Co., Ltd.

Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:

Henan Yonghe Pharmaceutical Co., Ltd.

Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:

Harbin Pharmaceutical Group Sanjing Mingshui Pharmaceutical Co., Ltd.

Nifedipine Tablets
Indication: Various types of hypertension and angina pectoris.
Manufacturer:

Shanghai Sine Tianping Pharmaceutical Co., Ltd.

Ranitidine Hydrochloride and Sodium Chloride Injection
Indication: Acid suppressants. Mainly used for: 1. Peptic ulcer bleeding, diffuse gastric mucosal lesions bleeding, anastomotic ulcer bleeding, prevention of rebleeding after gastric surgery, etc.; 2. Acute gastric mucosal damage complicated by stress state, and acute gastric mucosal damage caused by aspirin; also commonly used to prevent the occurrence of stress ulcer bleeding under stress state of severe diseases (such as cerebral hemorrhage, severe trauma, etc.); 3. Prevent gastric acid reflux combined with aspiration pneumonia after general anesthesia or major surgery and in weak and comatose patients.
Ranitidine Hydrochloride and Sodium Chloride Injection
Indication: Acid suppressants. Mainly used for: 1. Peptic ulcer bleeding, diffuse gastric mucosal lesions bleeding, anastomotic ulcer bleeding, prevention of rebleeding after gastric surgery, etc.; 2. Acute gastric mucosal damage complicated by stress state, and acute gastric mucosal damage caused by aspirin; also commonly used to prevent the occurrence of stress ulcer bleeding under stress state of severe diseases (such as cerebral hemorrhage, severe trauma, etc.); 3. Prevent gastric acid reflux combined with aspiration pneumonia after general anesthesia or major surgery and in weak and comatose patients.
Manufacturer:

Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.

Ranitidine Hydrochloride and Sodium Chloride Injection
Indication: Acid suppressants. Mainly used for: 1. Peptic ulcer bleeding, diffuse gastric mucosal lesions bleeding, anastomotic ulcer bleeding, prevention of rebleeding after gastric surgery, etc.; 2. Acute gastric mucosal damage complicated by stress state, and acute gastric mucosal damage caused by aspirin; also commonly used to prevent the occurrence of stress ulcer bleeding under stress state of severe diseases (such as cerebral hemorrhage, severe trauma, etc.); 3. Prevent gastric acid reflux combined with aspiration pneumonia after general anesthesia or major surgery and in weak and comatose patients.
Manufacturer:

Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.

Ranitidine Hydrochloride and Sodium Chloride Injection
Indication: Acid suppressants. Mainly used for: 1. Peptic ulcer bleeding, diffuse gastric mucosal lesions bleeding, anastomotic ulcer bleeding, prevention of rebleeding after gastric surgery, etc.; 2. Acute gastric mucosal damage complicated by stress state, and acute gastric mucosal damage caused by aspirin; also commonly used to prevent the occurrence of stress ulcer bleeding under stress state of severe diseases (such as cerebral hemorrhage, severe trauma, etc.); 3. Prevent gastric acid reflux combined with aspiration pneumonia after general anesthesia or major surgery and in weak and comatose patients.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.